Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 Gross Margin % is 38.24% as of Mar. 2026, which is 6% above its 10-year median of 36.05. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,911 Consumer Packaged Goods companies, Sheel Biotech ranks better than 72.63% on this metric.
The historical rank and industry rank for Sheel Biotech's Gross Margin % or its related term are showing as below:
NSE:SHEEL'
s Gross Margin % Range Over the Past 10 Years
Min: 33.32 Med: 36.05 Max: 38.24
Current: 38.24
During the past 5 years, the highestGross Margin % of Sheel Biotech was 38.24%. The lowest was 33.32%. And the median was 36.05%.
NSE:SHEEL's Gross Margin % is ranked better than 72.63% of 1911
companies
in the Consumer Packaged Goods industry
Industry Median: 26.35
vs NSE:SHEEL: 38.24
Sheel Biotech had a gross margin of 38.24% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Sheel Biotech was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sheel Biotech had a gross margin of 38.24% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sheel Biotech Gross Margin % Related Terms
Sheel Biotech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Gross Margin % Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Gross Margin %
33.32
33.77
37.83
36.05
38.24
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Gross Margin %
33.32
33.77
37.83
36.05
38.24
NSE:SHEEL vs ADM, BG, TSN: Gross Margin % Comparison
For the Farm Products subindustry, Sheel Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sheel Biotech (NSE:SHEEL) has a Gross Margin % of 38.24% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sheel Biotech and its competitors. This is near median its historical median of 36.05. Over the past decade, Sheel Biotech's Gross Margin % has ranged from 33.32 to 38.24. According to the industry distribution chart, Sheel Biotech ranks #523 out of 1911 companies in the Consumer Packaged Goods industry, placing it in the top 27.4%.
Is Sheel Biotech's Gross Margin % too high?
Sheel Biotech's current Gross Margin % of 38.24% is near median its 10-year median of 36.05. Over the past 10 years, this metric has ranged from a low of 33.32 to a high of 38.24. The Consumer Packaged Goods industry median Gross Margin % is 26.35. Sheel Biotech's value of 38.24% is 45.1% above this industry median. Based on the distribution chart, Sheel Biotech ranks #523 out of 1911 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Gross Margin % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #523 out of 1911 companies for Gross Margin %. This puts Sheel Biotech in the upper half of its industry. The industry median Gross Margin % is 26.35. Sheel Biotech's value of 38.24% is 45.1% above this benchmark. Historically, Sheel Biotech's own Gross Margin % has ranged from 33.32 to 38.24 over the past decade. While the company's 10-year median is 36.05 vs. the industry median of 26.35, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.35, based on 1,911 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current Gross Margin % of 38.24% is 45.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current Gross Margin % is 38.24%, which is near median its own 10-year median of 36.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Gross Margin % of 38.24%. The current Gross Margin % is 38.24%, which is near median its 10-year median of 36.05 and 45.1% above the Consumer Packaged Goods industry median of 26.35. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Gross Margin % is 38.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
